According to Privett:

"I've been practicing law for over 35 years. This gives me the ability to make decisions based on experience and sound reasoning being seasoned in trial combat." 

Studies Show 40% Increase in Bladder Cancer from Actos Use

If You or a Loved One Used the Drug, Actos, Understand Your Options and Let Privett Law Help You Get the Compensation You Deserve

Actos, a drug for the treatment of type-2 diabetes was approved in 1999 by the FDA. Since then, midterm results from a 10-year study found that patients using Actos for 12 months or longer have a 40% higher risk of developing bladder cancer. Additionally, Pioglitazone, the active ingredient in Actos may cause or worsen congestive heart failure. Other side effects include:


Hypoglycemia (low blood sugar)
* Hyperglycemia (high blood sugar)
* Runny nose and other cold symptoms
* Headache
* Muscle pain
* Tooth or mouth pain
* Sore throat
* Nausea, vomiting, loss of appetite
* Excessive tiredness
* Dark urine
* Yellowing of the skin or whites of the eyes
* Blurred vision or vision loss

Why Choose Privett Law?

There are many law firms out there; choosing the right one is important. Large firms have hundreds of clients and forget that each one is a person, not a case. At Privett Law I have the resources to fight large drug companies but our being a small firm allows me to develop a relationship with my clients and truly understand their needs.

Get Your Case Reviewed Today!


Waiting to seek legal counsel can be costly. If you wait too long:


* Evidence may be lost

* It may be harder to prove what caused your injuries

* The statute of limitations may run out and you will be barred from seeking damages

* The sooner you act, the sooner we are able to get the money you deserve for your injuries. If you took Actos but are unsure if
   you’ve been injured by the drug, our experts may be able to help you determine the extent of your injuries. 


Call 918-762-2705 or contact us online for a free case review today.


Actos and Bladder Cancer

Diabetes affects approximately 25.8 million people in the United States alone, which represents about 8.3% of the U.S. population. Type 2 diabetes is the most common type of diabetes and is particularly debilitating, as it is a chronic, or lifelong, disease marked by high levels of sugar in the blood. Because of the significant prevalence of diabetes and the dangers associated with the disease, a number of pharmaceutical companies have produced diabetes medications and marketed the drugs to consumers for the treatment of diabetes. Drug company Takeda Pharmaceuticals developed a type 2 diabetes medication called Actos (pioglitazone) which was approved by the FDA in 1999 and was indicated for the control of blood sugar levels in patients with the disease. Unfortunately, alleged Actos side effects, including bladder cancer, have led consumers to seek help from experienced Actos attorneys.

Actos Bladder Cancer Side Effects in Patients

Type 2 diabetes can cause extremely debilitating symptoms in patients, including blurred vision, erectile dysfunction and fatigue, and can lead to serious problems with the kidneys, eyes, heart, nerves and blood vessels. There are also significant long-term effects of diabetes, including an increased risk of stroke, heart failure and death. Many patients have taken the diabetes medication Actos to treat their type 2 diabetes, under the impression that the drug would effectively treat the disease without causing them any unnecessary harm. Unfortunately, recent Actos side effect information has indicated that patients exposed to high doses or a long duration of Actos treatment had an increased risk of bladder cancer.

In June 2011, the FDA issued an official safety announcement warning patients and healthcare professionals about the potential increased risk of bladder cancer in patients who use the diabetes medication Actos for more than one year. Based on bladder cancer side effect information, Actos has already been removed from the market in France and the use of Actos in new patients has been advised against in Germany. Although data regarding the bladder cancer side effects potentially linked to Actos may help patients in the future, consumers who have already taken the diabetes medication may still be at risk of suffering from bladder cancer. It is important that patients affected by bladder cancer understand the possible treatment options available to them, as well as the steps to take in protecting their legal rights regarding this matter.

Actos Lawsuits for Bladder Cancer

 

For consumers who are suddenly burdened with a bladder cancer diagnosis, it is important to enlist the help of an experienced Actos attorney. Actos attorneys are qualified in defective drug litigation and have the knowledge and skills necessary to help guide potential bladder cancer victims through the process of filing an Actos lawsuit against Takeda Pharmaceuticals. The main goal of Actos lawsuits is to help injured victims seek financial compensation for their injuries, the medical costs of treating their injuries, and the pain and suffering sustained by victims and their families. The bladder cancer side effects allegedly linked to the diabetes drug Actos are devastating and can severely alter the course of an affected individual's life. By hiring a knowledgeable Actos lawyer, victims of bladder cancer side effects can hold the allegedly negligent drug company liable for their injuries.


Actos Warning Labels

A new Actos FDA warning was issued in June 2011, warning patients and healthcare professionals about the increased risk of bladder cancer in patients who use Actos for more than one year. According to the FDA, information about this risk will be added to the Warnings and Precautions section of the Actos label and the label of other pioglitazone-containing medications. The patient Medication Guide for Actos has also been revised to include information about the risk of bladder cancer in Actos users. Although the FDA has taken steps to increase awareness about the potential bladder cancer side effects of Actos, more aggressive action has been taken by other countries, including Germany and France, to protect consumers from harm. After reviewing a recent epidemiological study conducted in France which suggests an increased risk of bladder cancer in Actos patients, France pulled Actos from the market and Germany has recommended against starting Actos in new patients.